Artificial Intelligence in Cerebrovascular Diseases
Vitahash · 08.10.2026
DOI: 10.68919/vitahash.2026.00007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vitahash, online erschienen am 08.10.2026. Verfasst von Inhye Jin und 7 weiteren Autor:innen.
Abstract (Originalsprache)
In management of cerebrovascular diseases, artificial intelligence (AI) emerges and plays a role through advancements in prediction, imaging, diagnosis, and treatment. Revolutionized AI-based tools allow us to catch a glimpse of possibility of rapid clinical workflows in detection, reducing time to the treatment while improving diagnostic accuracy compared to conventional methods. AI has the potential to facilitate primary prevention, improve acute detection, and provide additional decision-making beyond acute care. This review synthesizes applications of AI in major cerebrovascular diseases, introducing an overview of its efficiency and limitations.
Zitieren
APA
Jin, I., Darzi, E., Tangsrivimol, J. A., Wang, Z., Egger, J., Glicksberg, B. S., Zhang, C., & Krittanawong, C. (2026). Artificial Intelligence in Cerebrovascular Diseases. Vitahash. https://doi.org/10.68919/vitahash.2026.00007
Vancouver
Jin I, Darzi E, Tangsrivimol JA, Wang Z, Egger J, Glicksberg BS, et al. Artificial Intelligence in Cerebrovascular Diseases. Vitahash. 2026. doi:10.68919/vitahash.2026.00007
BibTeX
@article{Jin2026,
author = {Jin, Inhye and Darzi, Erfan and Tangsrivimol, Jonathan A and Wang, Zhen and Egger, Jan and Glicksberg, Benjamin S and Zhang, Cen and Krittanawong, Chayakrit},
title = {Artificial Intelligence in Cerebrovascular Diseases},
journal = {Vitahash},
year = {2026},
doi = {10.68919/vitahash.2026.00007}
}
EUVIMED